![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 14489 |
FusionGeneSummary for GBF1_NT5C2 |
![]() |
Fusion gene information | Fusion gene name: GBF1_NT5C2 | Fusion gene ID: 14489 | Hgene | Tgene | Gene symbol | GBF1 | NT5C2 | Gene ID | 80142 | 22978 |
Gene name | prostaglandin E synthase 2 | 5'-nucleotidase, cytosolic II | |
Synonyms | C9orf15|GBF-1|GBF1|PGES2|mPGES-2 | GMP|NT5B|PNT5|SPG45|SPG65|cN-II | |
Cytomap | 9q34.11 | 10q24.32-q24.33 | |
Type of gene | protein-coding | protein-coding | |
Description | prostaglandin E synthase 2GATE-binding factor 1gamma-interferon-activated transcriptional element-binding factor 1mPGE synthase-2membrane-associated prostaglandin E synthase 2microsomal prostaglandin E synthase-2prostaglandin-H(2) E-isomerase | cytosolic purine 5'-nucleotidase5'-nucleotidase (purine), cytosolic type BIMP-specific 5'-NT | |
Modification date | 20180519 | 20180523 | |
UniProtAcc | Q92538 | P49902 | |
Ensembl transtripts involved in fusion gene | ENST00000369983, ENST00000476019, | ENST00000343289, ENST00000404739, ENST00000369857, ENST00000423468, ENST00000470299, | |
Fusion gene scores | * DoF score | 11 X 7 X 8=616 | 2 X 6 X 2=24 |
# samples | 12 | 6 | |
** MAII score | log2(12/616*10)=-2.35989594508638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(6/24*10)=1.32192809488736 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: GBF1 [Title/Abstract] AND NT5C2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation | Oncogene involved fusion gene, in-frame and retained their domain. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | COAD | TCGA-CA-5254-01A | GBF1 | chr10 | 104019873 | + | NT5C2 | chr10 | 104866463 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000369983 | ENST00000343289 | GBF1 | chr10 | 104019873 | + | NT5C2 | chr10 | 104866463 | - |
In-frame | ENST00000369983 | ENST00000404739 | GBF1 | chr10 | 104019873 | + | NT5C2 | chr10 | 104866463 | - |
5CDS-intron | ENST00000369983 | ENST00000369857 | GBF1 | chr10 | 104019873 | + | NT5C2 | chr10 | 104866463 | - |
5CDS-intron | ENST00000369983 | ENST00000423468 | GBF1 | chr10 | 104019873 | + | NT5C2 | chr10 | 104866463 | - |
5CDS-intron | ENST00000369983 | ENST00000470299 | GBF1 | chr10 | 104019873 | + | NT5C2 | chr10 | 104866463 | - |
intron-3CDS | ENST00000476019 | ENST00000343289 | GBF1 | chr10 | 104019873 | + | NT5C2 | chr10 | 104866463 | - |
intron-3CDS | ENST00000476019 | ENST00000404739 | GBF1 | chr10 | 104019873 | + | NT5C2 | chr10 | 104866463 | - |
intron-intron | ENST00000476019 | ENST00000369857 | GBF1 | chr10 | 104019873 | + | NT5C2 | chr10 | 104866463 | - |
intron-intron | ENST00000476019 | ENST00000423468 | GBF1 | chr10 | 104019873 | + | NT5C2 | chr10 | 104866463 | - |
intron-intron | ENST00000476019 | ENST00000470299 | GBF1 | chr10 | 104019873 | + | NT5C2 | chr10 | 104866463 | - |
Top |
FusionProtFeatures for GBF1_NT5C2 |
![]() |
Hgene | Tgene |
GBF1 | NT5C2 |
Guanine-nucleotide exchange factor (GEF) for members ofthe Arf family of small GTPases involved in trafficking in theearly secretory pathway; its GEF activity initiates the coating ofnascent vesicles via the localized generation of activated ARFsthrough replacement of GDP with GTP. Recruitment to cis-Golgimembranes requires membrane association of Arf-GDP and can beregulated by ARF1, ARF3, ARF4 and ARF5. Involved in therecruitment of the COPI coat complex to the endoplasmic reticulumexit sites (ERES), and the endoplasmic reticulum-Golgiintermediate (ERGIC) and cis-Golgi compartments which implicatesARF1 activation. Involved in COPI vesicle-dependent retrogradetransport from the ERGIC and cis-Golgi compartments to theendoplasmic reticulum (ER) (PubMed:16926190, PubMed:17956946,PubMed:18003980, PubMed:12047556, PubMed:12808027,PubMed:19039328, PubMed:24213530). Involved in the trans-Golginetwork recruitment of GGA1, GGA2, GGA3, BIG1, BIG2, and the AP-1adaptor protein complex related to chlathrin-dependent transport;the function requires its GEF activity (probably at least in parton ARF4 and ARF5) (PubMed:23386609). Has GEF activity towards ARF1(PubMed:15616190). Has in vitro GEF activity towards ARF5 (Bysimilarity). Involved in the processing of PSAP (PubMed:17666033).Required for the assembly of the Golgi apparatus (PubMed:12808027,PubMed:18003980). The AMPK-phosphorylated form is involved inGolgi disassembly during mitotis and under stress conditions(PubMed:18063581, PubMed:23418352). May be involved in the COPIvesicle-dependent recruitment of PNPLA2 to lipid droplets;however, this function is under debate (PubMed:19461073,PubMed:22185782). In neutrophils, involved in G protein-coupledreceptor (GPCR)-mediated chemotaxis und superoxide production.Proposed to be recruited by phosphatidylinositol-phosphatesgenerated upon GPCR stimulation to the leading edge where itrecruits and activates ARF1, and is involved in recruitment ofGIT2 and the NADPH oxidase complex (PubMed:22573891).{ECO:0000250|UniProtKB:Q9R1D7, ECO:0000269|PubMed:12047556,ECO:0000269|PubMed:12808027, ECO:0000269|PubMed:15616190,ECO:0000269|PubMed:16926190, ECO:0000269|PubMed:17666033,ECO:0000269|PubMed:17956946, ECO:0000269|PubMed:18003980,ECO:0000269|PubMed:18063581, ECO:0000269|PubMed:19461073,ECO:0000269|PubMed:22185782, ECO:0000269|PubMed:22573891,ECO:0000269|PubMed:23386609, ECO:0000269|PubMed:23418352,ECO:0000269|PubMed:24213530, ECO:0000305|PubMed:19039328,ECO:0000305|PubMed:22573891}. | May have a critical role in the maintenance of aconstant composition of intracellular purine/pyrimidinenucleotides in cooperation with other nucleotidases.Preferentially hydrolyzes inosine 5'-monophosphate (IMP) and otherpurine nucleotides. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | >NT5C2 | chr10:104019873 | chr10:104866463 | ENST00000343289 | - | 2 | 18 | 549_561 | 58 | 562 | Compositional bias | Note=Asp/Glu-rich (acidic) |
Tgene | >NT5C2 | chr10:104019873 | chr10:104866463 | ENST00000404739 | - | 1 | 17 | 549_561 | 58 | 562 | Compositional bias | Note=Asp/Glu-rich (acidic) |
Tgene | >NT5C2 | chr10:104019873 | chr10:104866463 | ENST00000343289 | - | 2 | 18 | 202_210 | 58 | 562 | Region | Substrate binding |
Tgene | >NT5C2 | chr10:104019873 | chr10:104866463 | ENST00000404739 | - | 1 | 17 | 202_210 | 58 | 562 | Region | Substrate binding |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >GBF1 | chr10:104019873 | chr10:104866463 | ENST00000369983 | + | 3 | 40 | 1751_1854 | 54 | 1860 | Compositional bias | Note=Pro-rich |
Hgene | >GBF1 | chr10:104019873 | chr10:104866463 | ENST00000369983 | + | 3 | 40 | 692_882 | 54 | 1860 | Domain | SEC7 |
Hgene | >GBF1 | chr10:104019873 | chr10:104866463 | ENST00000369983 | + | 3 | 40 | 886_1370 | 54 | 1860 | Region | Phosphatidylinositol-phosphate binding%3B required for translocation to the leading edge and for ARF1 activation upon GPCR signaling |
Top |
FusionGeneSequence for GBF1_NT5C2 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_GBF1_ENST00000369983_chr10_104019873_+_NT5C2_ENST00000343289_chr10_104866463_-_558aa MVDKNIYIIQGEINIVVGAIKRNARWSTHTPLDEERDPLLHSFGHLKEVLNSITVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDST FPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETG FKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGS SHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQ GWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQV MRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNLFPLAPQEI >In-frame_GBF1_ENST00000369983_chr10_104019873_+_NT5C2_ENST00000404739_chr10_104866463_-_558aa MVDKNIYIIQGEINIVVGAIKRNARWSTHTPLDEERDPLLHSFGHLKEVLNSITVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDST FPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETG FKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGS SHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQ GWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQV MRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNLFPLAPQEI |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_GBF1_ENST00000369983_chr10_104019873_+_NT5C2_ENST00000343289_chr10_104866463_-_1674nt ATGGTGGATAAGAATATTTACATCATTCAAGGGGAGATTAACATTGTGGTTGGGGCCATCAAACGAAATGCCCGATGGAGCACCCATACA CCACTGGATGAAGAACGGGATCCTCTGCTGCATAGTTTCGGTCATCTAAAGGAGGTTTTAAACAGTATAACAGTGTACAAGTCCCCAGAG TATGAGTCCCTTGGTTTTGAGCTTACTGTGGAGAGATTAGTTTCTATTGGCTATCCCCAGGAGTTGCTCAGCTTTGCTTATGATTCTACA TTCCCTACCAGGGGACTTGTCTTTGACACACTGTATGGAAATCTTTTGAAAGTCGATGCCTATGGAAACCTCTTGGTCTGTGCACATGGA TTTAACTTTATAAGGGGACCAGAAACTAGAGAACAGTATCCAAATAAATTTATCCAGCGAGATGATACTGAAAGATTTTACATTCTGAAC ACACTATTCAACCTACCAGAGACCTACCTGTTGGCCTGCCTAGTAGATTTTTTTACTAATTGTCCCAGATATACCAGTTGTGAAACAGGA TTTAAAGATGGGGACCTCTTCATGTCCTACCGGAGTATGTTCCAGGATGTAAGAGATGCTGTTGACTGGGTTCATTACAAGGGCTCCCTT AAGGAAAAGACAGTTGAAAATCTTGAGAAGTATGTAGTCAAAGATGGAAAACTGCCTTTGCTTCTGAGCCGGATGAAGGAAGTAGGGAAA GTATTTCTTGCTACCAACAGTGACTATAAATATACAGATAAAATTATGACTTACCTGTTTGACTTCCCACATGGCCCCAAGCCTGGGAGC TCCCATCGACCATGGCAGTCCTACTTTGACTTGATCTTGGTGGATGCACGGAAACCACTCTTTTTTGGAGAAGGCACAGTACTGCGTCAG GTGGATACTAAAACTGGCAAGCTGAAAATTGGTACCTACACAGGGCCCCTACAGCATGGTATCGTCTACTCAGGAGGTTCTTCTGATACG ATCTGTGACCTGTTGGGAGCCAAGGGAAAAGACATTTTGTATATTGGAGATCACATTTTTGGGGACATTTTAAAATCAAAGAAACGGCAA GGGTGGCGAACTTTTTTGGTGATTCCTGAACTCGCACAGGAGCTACATGTCTGGACTGACAAGAGTTCACTTTTCGAAGAACTTCAGAGC TTGGATATTTTCTTGGCTGAACTCTACAAGCATCTTGACAGCAGTAGCAATGAGCGTCCAGACATCAGTTCCATCCAGAGACGTATTAAG AAAGTAACTCATGACATGGACATGTGCTATGGGATGATGGGAAGCCTGTTTCGCAGTGGCTCCCGGCAGACCCTTTTTGCCAGTCAAGTG ATGCGTTATGCTGACCTCTATGCAGCATCTTTCATCAACCTGCTGTATTACCCTTTCAGCTACCTCTTCAGGGCTGCCCATGTCTTGATG CCTCATGAATCAACGGTGGAGCACACACACGTAGATATCAATGAGATGGAGTCTCCTCTTGCCACCCGGAACCGCACATCAGTGGATTTC AAAGACACTGACTACAAGCGGCACCAGCTGACACGGTCAATTAGTGAGATTAAACCTCCCAACCTCTTCCCACTGGCCCCCCAGGAAATT >In-frame_GBF1_ENST00000369983_chr10_104019873_+_NT5C2_ENST00000404739_chr10_104866463_-_1674nt ATGGTGGATAAGAATATTTACATCATTCAAGGGGAGATTAACATTGTGGTTGGGGCCATCAAACGAAATGCCCGATGGAGCACCCATACA CCACTGGATGAAGAACGGGATCCTCTGCTGCATAGTTTCGGTCATCTAAAGGAGGTTTTAAACAGTATAACAGTGTACAAGTCCCCAGAG TATGAGTCCCTTGGTTTTGAGCTTACTGTGGAGAGATTAGTTTCTATTGGCTATCCCCAGGAGTTGCTCAGCTTTGCTTATGATTCTACA TTCCCTACCAGGGGACTTGTCTTTGACACACTGTATGGAAATCTTTTGAAAGTCGATGCCTATGGAAACCTCTTGGTCTGTGCACATGGA TTTAACTTTATAAGGGGACCAGAAACTAGAGAACAGTATCCAAATAAATTTATCCAGCGAGATGATACTGAAAGATTTTACATTCTGAAC ACACTATTCAACCTACCAGAGACCTACCTGTTGGCCTGCCTAGTAGATTTTTTTACTAATTGTCCCAGATATACCAGTTGTGAAACAGGA TTTAAAGATGGGGACCTCTTCATGTCCTACCGGAGTATGTTCCAGGATGTAAGAGATGCTGTTGACTGGGTTCATTACAAGGGCTCCCTT AAGGAAAAGACAGTTGAAAATCTTGAGAAGTATGTAGTCAAAGATGGAAAACTGCCTTTGCTTCTGAGCCGGATGAAGGAAGTAGGGAAA GTATTTCTTGCTACCAACAGTGACTATAAATATACAGATAAAATTATGACTTACCTGTTTGACTTCCCACATGGCCCCAAGCCTGGGAGC TCCCATCGACCATGGCAGTCCTACTTTGACTTGATCTTGGTGGATGCACGGAAACCACTCTTTTTTGGAGAAGGCACAGTACTGCGTCAG GTGGATACTAAAACTGGCAAGCTGAAAATTGGTACCTACACAGGGCCCCTACAGCATGGTATCGTCTACTCAGGAGGTTCTTCTGATACG ATCTGTGACCTGTTGGGAGCCAAGGGAAAAGACATTTTGTATATTGGAGATCACATTTTTGGGGACATTTTAAAATCAAAGAAACGGCAA GGGTGGCGAACTTTTTTGGTGATTCCTGAACTCGCACAGGAGCTACATGTCTGGACTGACAAGAGTTCACTTTTCGAAGAACTTCAGAGC TTGGATATTTTCTTGGCTGAACTCTACAAGCATCTTGACAGCAGTAGCAATGAGCGTCCAGACATCAGTTCCATCCAGAGACGTATTAAG AAAGTAACTCATGACATGGACATGTGCTATGGGATGATGGGAAGCCTGTTTCGCAGTGGCTCCCGGCAGACCCTTTTTGCCAGTCAAGTG ATGCGTTATGCTGACCTCTATGCAGCATCTTTCATCAACCTGCTGTATTACCCTTTCAGCTACCTCTTCAGGGCTGCCCATGTCTTGATG CCTCATGAATCAACGGTGGAGCACACACACGTAGATATCAATGAGATGGAGTCTCCTCTTGCCACCCGGAACCGCACATCAGTGGATTTC AAAGACACTGACTACAAGCGGCACCAGCTGACACGGTCAATTAGTGAGATTAAACCTCCCAACCTCTTCCCACTGGCCCCCCAGGAAATT |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_GBF1_ENST00000369983_chr10_104019873_+_NT5C2_ENST00000343289_chr10_104866463_-_5423nt AGTTACCACGTCAGTGAGCTGACAGGGAAGGTACCCGGCTCTACTGCCCGTCCCGGACGACTCATCCTGGCGGACTGTGCAGTCCCACCC TGACTTCGGCCTCAATTTCCAGGAAACAGGCTCCTTCTCTTCTCCCATCTGCTACCAGAGCCGGGAGAGCTGCTCGGAGACGCCTCCGGG GTGCGGGCTGGACATGAGCAGCGGCTGCCGGTCCTGGGACTAGGCCCCGCCATTTTGGATCCGCTGACAGGTTTGCCAAGATGGTGGATA AGAATATTTACATCATTCAAGGGGAGATTAACATTGTGGTTGGGGCCATCAAACGAAATGCCCGATGGAGCACCCATACACCACTGGATG AAGAACGGGATCCTCTGCTGCATAGTTTCGGTCATCTAAAGGAGGTTTTAAACAGTATAACAGTGTACAAGTCCCCAGAGTATGAGTCCC TTGGTTTTGAGCTTACTGTGGAGAGATTAGTTTCTATTGGCTATCCCCAGGAGTTGCTCAGCTTTGCTTATGATTCTACATTCCCTACCA GGGGACTTGTCTTTGACACACTGTATGGAAATCTTTTGAAAGTCGATGCCTATGGAAACCTCTTGGTCTGTGCACATGGATTTAACTTTA TAAGGGGACCAGAAACTAGAGAACAGTATCCAAATAAATTTATCCAGCGAGATGATACTGAAAGATTTTACATTCTGAACACACTATTCA ACCTACCAGAGACCTACCTGTTGGCCTGCCTAGTAGATTTTTTTACTAATTGTCCCAGATATACCAGTTGTGAAACAGGATTTAAAGATG GGGACCTCTTCATGTCCTACCGGAGTATGTTCCAGGATGTAAGAGATGCTGTTGACTGGGTTCATTACAAGGGCTCCCTTAAGGAAAAGA CAGTTGAAAATCTTGAGAAGTATGTAGTCAAAGATGGAAAACTGCCTTTGCTTCTGAGCCGGATGAAGGAAGTAGGGAAAGTATTTCTTG CTACCAACAGTGACTATAAATATACAGATAAAATTATGACTTACCTGTTTGACTTCCCACATGGCCCCAAGCCTGGGAGCTCCCATCGAC CATGGCAGTCCTACTTTGACTTGATCTTGGTGGATGCACGGAAACCACTCTTTTTTGGAGAAGGCACAGTACTGCGTCAGGTGGATACTA AAACTGGCAAGCTGAAAATTGGTACCTACACAGGGCCCCTACAGCATGGTATCGTCTACTCAGGAGGTTCTTCTGATACGATCTGTGACC TGTTGGGAGCCAAGGGAAAAGACATTTTGTATATTGGAGATCACATTTTTGGGGACATTTTAAAATCAAAGAAACGGCAAGGGTGGCGAA CTTTTTTGGTGATTCCTGAACTCGCACAGGAGCTACATGTCTGGACTGACAAGAGTTCACTTTTCGAAGAACTTCAGAGCTTGGATATTT TCTTGGCTGAACTCTACAAGCATCTTGACAGCAGTAGCAATGAGCGTCCAGACATCAGTTCCATCCAGAGACGTATTAAGAAAGTAACTC ATGACATGGACATGTGCTATGGGATGATGGGAAGCCTGTTTCGCAGTGGCTCCCGGCAGACCCTTTTTGCCAGTCAAGTGATGCGTTATG CTGACCTCTATGCAGCATCTTTCATCAACCTGCTGTATTACCCTTTCAGCTACCTCTTCAGGGCTGCCCATGTCTTGATGCCTCATGAAT CAACGGTGGAGCACACACACGTAGATATCAATGAGATGGAGTCTCCTCTTGCCACCCGGAACCGCACATCAGTGGATTTCAAAGACACTG ACTACAAGCGGCACCAGCTGACACGGTCAATTAGTGAGATTAAACCTCCCAACCTCTTCCCACTGGCCCCCCAGGAAATTACACACTGCC ATGACGAAGATGATGATGAAGAGGAGGAGGAGGAGGAAGAATAAGGAGGAAAACCAAAACCCCAAGCACCCATTAAACAAGTCCTGGCAG GACTCACAGGAACAAACGAGGTCCCTGTTAGGGTTCTACTCGGGGGAGGGAGGGGGCTCCATGAAAGGTACGTCTGAAAAGTTTCTGAAG ATTTTATTATCATAGATACTTGTTTTGGTTTTGTGTATCTGTACTCTCTGCAGATGGTCCAAAATTGTAATGGAGTCTGTATTAGAAGAA AATAAGGGTAAAATCAGGCTGAACTGCATGTATATGGCTCCACTGTGGCTTGTGACACTTTTAAAATCATCCGTATGTCAGTGTATCTGG ATACACGAGGAAAAGGAAAGAGTCTCAGAGTGGAACAAAGAGTGGGAAGAGGTGATCTGTAATGTTACAAATTGTGCTATTACTCCAAGG TCCAACTTTTCCAGTGCATTACATGGTATTGTATATCAGTGGAGAAATGTATTATTTCCATGATCAAATGTAGTCTCTGTTAAGGTCAAG TTTTCTTTTATAAGCCTTTAATTCATCCTCAGTGACTCTGGCAAGGCTGCTTCTCTATCACTGGCTTTGCACAGAAGTATGCTCTACTTG CGTTGCTTTAGGGCAGGATTCTATTTTGAGGGAAAAGACAGTATCCTTATTACCTTTTGTTTGTTTAATAGCACAAATGCTTATTTGTTA TCCAAAAACAACCTCCTTCTTATCTGTGATAAATCTATAGAAAGAATTTAGCTGCAAGTGGACAAAGGAACAAGCCCCCAGAAAAGAAAG GGAAGAACTGCCTTCTTATACTACAGAACATGCATTAGTGTGGGCTATATAGCTGTGGCTCATGCTACCCAATTCCAGATTTCTTTGTCC TCTAAGAGTTGATTGCTGTATATTAAAATTGAACATCAGAGGATGGGAAGAGGGCTCTGTAAGCCAGAACCTTACTAAAGTAGAGGGCAC AATCAGTGTGAATAAATTCACTTCAGAATCTCAAGTCAAGGCCAGGCACGGCGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCGAG ACAGGCGGATCACCTGAGGTCGGGAGTTCGAGACCAGCCTTACCAACATGGAGAAACCCCATCTCTACTAAAAATACAAAATTACCTGGG CGTGGTGGTGCATGCCTGTAATCCCATCATCTACTCAGGAGGCTGAGGCAGGAGAATTGCTTGAACCCAGGAGGCGGAGGTTGCAGTGAG CCAGGATTGTGCCATTGCACTCCAGCCTGGGCAACAAGAACAAAACTCCATCTCAAAAAATAAAAATCCCAATCCCAAGTCGAAATCACC TCTTGTTTTAAACAAGAATGAATCATTACTGTGTATGTTAGGGTATTAAAACTGTTTCACCAGTACAGTGAAAGTTGTTTCAACATTTTA AACAAACAGTGGTTATAGACTCTTTCTTTAACCATTGTATATTTTCTTCCATTCTTGTCATTGGTCAATAGGGGAGGGTAGATTAGCTGC TCCAGAATTCAATAAAGTGTAATATTTCTAACGGTGACTTTGACCTATTCTGTAGTACAACTGTAATAGCTATTGGTCTTCAAGTGGGTT TAGATTTGGTGACATCAGTTTGATATTCTCTTAAAGGAAATAAATATTCAAGAACTGATTATGTTCTAACATGATTATATTCATGGTGTT ACATAGGCCTCAATTTTTTCACAGAAAGATTTTTGGAACAGGACTGTGAAGTGAGGCTTTTTAAAAAATTATTTTATAAGCAGAGAACAC AGCCTGATAACTTAGTCAAGGATATACTGTCTGTCTCACTACTTTGGACTTATATGGCTTCAGATTAAGTCATCCAAGAAACATACATAC ATTCTAAATGGTATATATTGGGAATATATGCCCCTTTAAAAGAATCAGGTCAGAAATGCAATAACAATTAGACTAGACTGTTGCCCGTGT TAGGAGAATGTGTGGTCATCCTAGTTACTAATTACTCTCACTCAAGATGGAGATGTTGTCCAGTTTAACATAGTCTTAAGTTTTCTTAAA CCCAAATAATTTATGAGTAGCTTATTACATCTGCAGAGCTACCTTATTATAATAGTACATTTACATATTGTCTCTTTTAGAGTAAGGACC ACATGATTGCTTTGCTTTAATTTACCACTTTTTGTATTGCATCCATATAAGAGTGTCTTACTAGCCAGATGATTCCATGGCAAATGATTC TCTGGGTCCAAAGATCGGAAAGTGAAAAGCACACAGCTGGAATAAGCAACAACTCCACTGCTAGTTACAGCTCTCCGTAGGACCACCAAA ACGTATTCAAGAGCTCTAGGATTCCATAAGACCCAGAGCAAAATGGTGCCTCTCTGTATATTATTCTTAAGAGTGTGCTGGGAAGTCAAT GGTCCATGGGTAGGCAGGGCAGCTGTAACTGGGCTTTTTAAAACAAATTATGAGTTTTCTCTCTGTTGCCAGTAGTTAAGGAAGCTGAAC TTAAAAGGTATACTTTTTTCCTTAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAATCCTGCGGAGTTTTATACCGTGAGAAGACCATTCT GCCACTTCTTTTGAGAATTTTTTCCCAGGCATTTTGAAAACACTATAGGCATTGTAGAACACCAGGCAACCCCTTCTTGGTTGCTAGACT GAACTCCCAACCTTACAGCATGTACTGACAGGTCCCCTAGCCTCCCCAGCAGTTGGTCAGTGGTACAGCAGACCCAGGCCCTGCTGGGTT TCCTTGGGCAGAGGAATTGCCCAGTACATTCATTCATCTCTGCAAAGATAGATAGTCAGTGAAAACTCTGATGGTGTACTTCAGAAAAGT TGGTCACAGCCAAGAAAGTTTAGGGTTCTATTTAGACCTAAGATTTTTCTCTTGCCATAAGCATACCTCTGCTGAGACCTAAAATAATAA CGCAAACCCTTCAAGCTACCCTAAGATACTTTTAGAAGTCGTTTTTAATAGAACTACAAATCCTTAAGTCACATTAGCATTGTTAAGAAA CCACTTTAAAAAGCCACATGCAGTTGCATGTCAGATTTAGAAGTATTTTGTCCATGTTTAGGTATTTCTAAATCAGATGTATTTATTTAA GAAATACTTTGTCAACAACTTTAAAGCCCAGCAATTTTTCCAAGGCTGCCTGGTCATTTTAAAATAAATACTCTGCTTATTCACCACGAA TAGCCTGAGACAACTACATATTTAAGTCTGTATTAGGGTAGGAACCTTACCCACATTCCATGTTATGGAAACTATTTAATCTGTCTTTGA TGGTGGGAAAAATGGTAACTATGATCTAGCTATTGCCATACAGTTAACGCTCCAATTCCTCACTGGGCTTAGTAGTTTAGGGCTCAAATA CTTATGTTTCTCATGATGATCTTTAGTGGTGATCAGGGAATCCAGCTTTTCTTAAAAGTTTTTCCTCAAATAGAACAATTTCAAATGATA >In-frame_GBF1_ENST00000369983_chr10_104019873_+_NT5C2_ENST00000404739_chr10_104866463_-_3589nt AGTTACCACGTCAGTGAGCTGACAGGGAAGGTACCCGGCTCTACTGCCCGTCCCGGACGACTCATCCTGGCGGACTGTGCAGTCCCACCC TGACTTCGGCCTCAATTTCCAGGAAACAGGCTCCTTCTCTTCTCCCATCTGCTACCAGAGCCGGGAGAGCTGCTCGGAGACGCCTCCGGG GTGCGGGCTGGACATGAGCAGCGGCTGCCGGTCCTGGGACTAGGCCCCGCCATTTTGGATCCGCTGACAGGTTTGCCAAGATGGTGGATA AGAATATTTACATCATTCAAGGGGAGATTAACATTGTGGTTGGGGCCATCAAACGAAATGCCCGATGGAGCACCCATACACCACTGGATG AAGAACGGGATCCTCTGCTGCATAGTTTCGGTCATCTAAAGGAGGTTTTAAACAGTATAACAGTGTACAAGTCCCCAGAGTATGAGTCCC TTGGTTTTGAGCTTACTGTGGAGAGATTAGTTTCTATTGGCTATCCCCAGGAGTTGCTCAGCTTTGCTTATGATTCTACATTCCCTACCA GGGGACTTGTCTTTGACACACTGTATGGAAATCTTTTGAAAGTCGATGCCTATGGAAACCTCTTGGTCTGTGCACATGGATTTAACTTTA TAAGGGGACCAGAAACTAGAGAACAGTATCCAAATAAATTTATCCAGCGAGATGATACTGAAAGATTTTACATTCTGAACACACTATTCA ACCTACCAGAGACCTACCTGTTGGCCTGCCTAGTAGATTTTTTTACTAATTGTCCCAGATATACCAGTTGTGAAACAGGATTTAAAGATG GGGACCTCTTCATGTCCTACCGGAGTATGTTCCAGGATGTAAGAGATGCTGTTGACTGGGTTCATTACAAGGGCTCCCTTAAGGAAAAGA CAGTTGAAAATCTTGAGAAGTATGTAGTCAAAGATGGAAAACTGCCTTTGCTTCTGAGCCGGATGAAGGAAGTAGGGAAAGTATTTCTTG CTACCAACAGTGACTATAAATATACAGATAAAATTATGACTTACCTGTTTGACTTCCCACATGGCCCCAAGCCTGGGAGCTCCCATCGAC CATGGCAGTCCTACTTTGACTTGATCTTGGTGGATGCACGGAAACCACTCTTTTTTGGAGAAGGCACAGTACTGCGTCAGGTGGATACTA AAACTGGCAAGCTGAAAATTGGTACCTACACAGGGCCCCTACAGCATGGTATCGTCTACTCAGGAGGTTCTTCTGATACGATCTGTGACC TGTTGGGAGCCAAGGGAAAAGACATTTTGTATATTGGAGATCACATTTTTGGGGACATTTTAAAATCAAAGAAACGGCAAGGGTGGCGAA CTTTTTTGGTGATTCCTGAACTCGCACAGGAGCTACATGTCTGGACTGACAAGAGTTCACTTTTCGAAGAACTTCAGAGCTTGGATATTT TCTTGGCTGAACTCTACAAGCATCTTGACAGCAGTAGCAATGAGCGTCCAGACATCAGTTCCATCCAGAGACGTATTAAGAAAGTAACTC ATGACATGGACATGTGCTATGGGATGATGGGAAGCCTGTTTCGCAGTGGCTCCCGGCAGACCCTTTTTGCCAGTCAAGTGATGCGTTATG CTGACCTCTATGCAGCATCTTTCATCAACCTGCTGTATTACCCTTTCAGCTACCTCTTCAGGGCTGCCCATGTCTTGATGCCTCATGAAT CAACGGTGGAGCACACACACGTAGATATCAATGAGATGGAGTCTCCTCTTGCCACCCGGAACCGCACATCAGTGGATTTCAAAGACACTG ACTACAAGCGGCACCAGCTGACACGGTCAATTAGTGAGATTAAACCTCCCAACCTCTTCCCACTGGCCCCCCAGGAAATTACACACTGCC ATGACGAAGATGATGATGAAGAGGAGGAGGAGGAGGAAGAATAAGGAGGAAAACCAAAACCCCAAGCACCCATTAAACAAGTCCTGGCAG GACTCACAGGAACAAACGAGGTCCCTGTTAGGGTTCTACTCGGGGGAGGGAGGGGGCTCCATGAAAGGTACGTCTGAAAAGTTTCTGAAG ATTTTATTATCATAGATACTTGTTTTGGTTTTGTGTATCTGTACTCTCTGCAGATGGTCCAAAATTGTAATGGAGTCTGTATTAGAAGAA AATAAGGGTAAAATCAGGCTGAACTGCATGTATATGGCTCCACTGTGGCTTGTGACACTTTTAAAATCATCCGTATGTCAGTGTATCTGG ATACACGAGGAAAAGGAAAGAGTCTCAGAGTGGAACAAAGAGTGGGAAGAGGTGATCTGTAATGTTACAAATTGTGCTATTACTCCAAGG TCCAACTTTTCCAGTGCATTACATGGTATTGTATATCAGTGGAGAAATGTATTATTTCCATGATCAAATGTAGTCTCTGTTAAGGTCAAG TTTTCTTTTATAAGCCTTTAATTCATCCTCAGTGACTCTGGCAAGGCTGCTTCTCTATCACTGGCTTTGCACAGAAGTATGCTCTACTTG CGTTGCTTTAGGGCAGGATTCTATTTTGAGGGAAAAGACAGTATCCTTATTACCTTTTGTTTGTTTAATAGCACAAATGCTTATTTGTTA TCCAAAAACAACCTCCTTCTTATCTGTGATAAATCTATAGAAAGAATTTAGCTGCAAGTGGACAAAGGAACAAGCCCCCAGAAAAGAAAG GGAAGAACTGCCTTCTTATACTACAGAACATGCATTAGTGTGGGCTATATAGCTGTGGCTCATGCTACCCAATTCCAGATTTCTTTGTCC TCTAAGAGTTGATTGCTGTATATTAAAATTGAACATCAGAGGATGGGAAGAGGGCTCTGTAAGCCAGAACCTTACTAAAGTAGAGGGCAC AATCAGTGTGAATAAATTCACTTCAGAATCTCAAGTCAAGGCCAGGCACGGCGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCGAG ACAGGCGGATCACCTGAGGTCGGGAGTTCGAGACCAGCCTTACCAACATGGAGAAACCCCATCTCTACTAAAAATACAAAATTACCTGGG CGTGGTGGTGCATGCCTGTAATCCCATCATCTACTCAGGAGGCTGAGGCAGGAGAATTGCTTGAACCCAGGAGGCGGAGGTTGCAGTGAG CCAGGATTGTGCCATTGCACTCCAGCCTGGGCAACAAGAACAAAACTCCATCTCAAAAAATAAAAATCCCAATCCCAAGTCGAAATCACC TCTTGTTTTAAACAAGAATGAATCATTACTGTGTATGTTAGGGTATTAAAACTGTTTCACCAGTACAGTGAAAGTTGTTTCAACATTTTA AACAAACAGTGGTTATAGACTCTTTCTTTAACCATTGTATATTTTCTTCCATTCTTGTCATTGGTCAATAGGGGAGGGTAGATTAGCTGC TCCAGAATTCAATAAAGTGTAATATTTCTAACGGTGACTTTGACCTATTCTGTAGTACAACTGTAATAGCTATTGGTCTTCAAGTGGGTT |
Top |
FusionGenePPI for GBF1_NT5C2 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
GBF1 | YWHAG, COPG1, KBTBD7, VCP, HDAC6, EGFR, PNPLA2, YWHAB, BIRC6, EPS15L1, NUP85, PLEC, CCAR2, NCAPH, RABL6, IRS4, IVNS1ABP, FBXW11, BTRC, SPACA1, PNKD, LYPD3, KIF4A, PUS7, RBM26, VARS, NTRK1, SRPK2, FBXO7, ZSCAN26, FOXB1, FOXG1, FOXI2, FOXL1, CDC73, TMEM206, CHRM3, GML, MILR1, DLK2, NPY2R, EPHA1, UBC | NT5C2 | NUDT18, NME7, NT5C2, FXR2, MOB3B, NOC4L, CALM1, GNPDA1, HERC4, ADSL, API5, BTF3L4, SZRD1, DRG2, EHD4, RAD23A, USP5, WARS, ASB2, ATP5O, SDCBP, MOB1B, MOB3C, HSPBP1, PTGES3, NTRK1, FBF1, CEP19, DUSP3, SNX15, TRIM25 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | GBF1 | chr10:104019873 | chr10:104866463 | ENST00000369983 | + | 3 | 40 | 1_380 | 54 | 1860 | RAB1B |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for GBF1_NT5C2 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | NT5C2 | P49902 | DB00811 | Ribavirin | Cytosolic purine 5'-nucleotidase | small molecule | approved |
Top |
RelatedDiseases for GBF1_NT5C2 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | NT5C2 | C1961102 | Precursor Cell Lymphoblastic Leukemia Lymphoma | 1 | CTD_human |